Isletopathy in type 2 diabetes mellitus: Implications of islet RAS, islet fibrosis, islet amyloid, remodeling, and oxidative stress

被引:64
作者
Hayden, Melvin R. [1 ]
Sowers, James R.
机构
[1] Univ Missouri, Sch Med, Dept Internal Med, Columbia, MO 65211 USA
[2] Univ Missouri, Sch Med, Dept Diabet Endocrinol & Metab, Columbia, MO 65211 USA
[3] Univ Missouri, Sch Med, Dept Pharmacol & Physiol, Columbia, MO 65211 USA
[4] Univ Missouri, Sch Med, Dept Diabet, Columbia, MO 65211 USA
[5] Univ Missouri, Sch Med, Cardiovasc Dis Res Grp, Columbia, MO 65211 USA
关键词
D O I
10.1089/ars.2007.1610
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review focuses primarily on islet structural and functional changes related to an activated islet renin angiotensin system (RAS), islet oxidative-redox imbalance, the concurrence of islet fibrosis (pericapillary, intra- and peri-islet), and islet amyloid deposition ( pericapillary, intra- and peri-islet). The islet-acinar-portal vascular pathway and the emerging important anatomical and functional region, the islet-exocrine interface, are also discussed. Because there is an associated histopathological islet disease in type 2 diabetes mellitus (T2DM), the term isletopathy is discussed in detail. The isletopathy in T2DM is equally important as the other complications of diabetes. Special stains and special lighting ( bright field and crossed polarized light) are utilized, along with light and transmission electron microscopy, in order to better understand islet structural remodeling in T2DM. The importance of an isletopathy in T2DM is supported by numerous remodeling changes within the islet and the islet-exocrine interface. While some of the structural findings are only preliminary observations, additional investigation in this area should lead to the development of new pathophysiological concepts and new therapies regarding the prevention and treatment of T2DM.
引用
收藏
页码:891 / 910
页数:20
相关论文
共 71 条
  • [1] Amos AF, 1997, DIABETIC MED, V14, pS7, DOI 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO
  • [2] 2-I
  • [3] Impact of endoplasmic reticulum stress pathway on pancreatic β-cells and diabetes mellitus
    Araki, E
    Oyadomari, S
    Mori, M
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 228 (10) : 1213 - 1217
  • [4] Endothelial/pericyte interactions
    Armulik, A
    Abramsson, A
    Betsholtz, C
    [J]. CIRCULATION RESEARCH, 2005, 97 (06) : 512 - 523
  • [5] Role of oxidative stress in diabetic complications - A new perspective on an old paradigm
    Baynes, JW
    Thorpe, SR
    [J]. DIABETES, 1999, 48 (01) : 1 - 9
  • [6] Association between endocrine pancreas and ductal system. More than an epiphenomenon of endocrine differentiation and development?
    Bertelli, E
    Bendayan, M
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2005, 53 (09) : 1071 - 1086
  • [7] The pathobiology of diabetic complications - A unifying mechanism
    Brownlee, M
    [J]. DIABETES, 2005, 54 (06) : 1615 - 1625
  • [8] β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes
    Butler, AE
    Janson, J
    Bonner-Weir, S
    Ritzel, R
    Rizza, RA
    Butler, PC
    [J]. DIABETES, 2003, 52 (01) : 102 - 110
  • [9] Diabetes due to a progressive defect in β-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat) -: A new model for type 2 diabetes
    Butler, AE
    Jang, J
    Gurlo, T
    Carty, MD
    Soeller, WC
    Butler, PC
    [J]. DIABETES, 2004, 53 (06) : 1509 - 1516
  • [10] CALRK A, 1995, DIABETES RES CLIN S, pS39